CABA Trading Analysis - 11/13/2026 11:27 AM — TRU-SENTIMENT

CABA (Cabaletta Bio Inc. Common Stock) at $1.27. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $1,610 vs put $0. RSI 45.7.

TRU-SENTIMENT · DeltaNeutral

CABA Trading Analysis - 11/13/2026 11:27 AM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

CABA (Cabaletta Bio Inc. Common Stock) at $1.27. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $1,610 vs put $0. RSI 45.7.

Symbol
CABA
Price
$1.27
Article bias (separate from True Sentiment)
neutral
Conviction
medium
Published
2026-11-13 11:27:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (delta 40-60 only):

Call Volume: $1,610 (100.00%) Put Volume: $0 (0.00%) Total: $1,610

Sentiment: Bullish. 1 call trade, 23 call contracts, 0 puts. Pure directional conviction is call-heavy but sample is tiny (1 trade). Divergence: technicals bearish, options sentiment bullish — confirmed by spread recommendation "Wait for alignment."

Key Statistics: CABA

$1.27 -5.90%
52-Week Range
$1.18 - $4.23
Market Cap
$275.04M
P/E (TTM)
N/A
PEG Ratio
N/A
Beta
3.84
Next Earnings
N/A
Avg Volume
$4.35M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

EPS (trailing 12 mo)$-1.33
Market cap$275.04M
Shares outstanding215.7M

Dividend

Dividend yield0.00%

Risk & range

Beta3.84
52-week low$1.18
52-week high$4.23
Historical volatility92.6%

Ownership & trading

Institutional ownership46.4%
Average daily volume4.6M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

The following context items are based on general knowledge and are separated from the data-driven analysis below.

  • Cabaletta Bio (CABA) is a clinical-stage biotech focused on CAR-T therapies for autoimmune diseases; recent pipeline updates from mid-2026 showed mixed early trial signals that kept speculative interest high.
  • In October 2026, broader biotech sector weakness and a risk-off move in small-cap names pressured low-priced catalysts like CABA.
  • No confirmed earnings date is publicly flagged for early December 2026, but biotech names often see volatility around trial readouts or FDA communications.
  • High beta (3.84 per fundamentals) suggests CABA routinely moves multiples of the broader market on sentiment shifts.
  • Context relation: News-driven speculation aligns with the bullish options-flow read, while the weak technicals reflect prior dilution and sector de-risking.

Fundamental Analysis

Based strictly on the embedded FUNDAMENTALS data for CABA:

  • Trailing EPS is -1.33; company is not profitable with no positive earnings trend.
  • Trailing P/E: null; Forward P/E: null; PEG: null — no valuation multiple available due to negative earnings.
  • Profit margins, ROE, revenue growth, and debt/equity are null — not disclosed in data.
  • Market cap is $275,043,000 with 215,720,000 shares outstanding.
  • Dividend yield 0.00%; no dividend.
  • Beta is 3.84 (very high risk); 52-week range $1.18 to $4.23; current price near 52-week low zone.
  • Institutional ownership 46.41%; average volume 4,604,000.
  • Historical volatility 92.6% — extreme.
  • Analyst consensus and target price: null / not available.
  • Fundamentals (no earnings, high volatility) diverge from bullish options sentiment and confirm weak technical backdrop.

Current Market Position

Current price from indicators: $1.36 (1.35 formatted). Daily close on 2026-11-12 was $1.36 (1.35). Minute bars show 2026-11-12 open $1.43, low $1.34, close $1.36; 2026-11-13 10:55 bar at $1.28 (1.27) with tight $1.27–$1.28 range and low volume late bars.

Key observations from data: 30-day low $1.18 (2026-11-05), 30-day high $2.14 (early Oct). Price sits in lower 12% of 30-day range. Intraday momentum is flat-to-soft with compressed ranges near $1.27–$1.28 on 2026-11-13.

Technical Analysis

Technical Indicators

Current Price
$1.36
SMA 5
$1.41
SMA 20
$1.45
SMA 50
$1.97
RSI 14
45.66
MACD
-0.16
Signal
-0.13
Hist
-0.03
BB Mid
$1.45
BB Up
$1.63
BB Low
$1.27
ATR 14
$0.15

Price below SMA 5 ($1.41), SMA 20 ($1.45), and far below SMA 50 ($1.97) — bearish alignment, no bullish crossover. RSI 45.66 shows weak momentum, not oversold. MACD negative with histogram -0.03 confirms bearish pressure. Bollinger lower band $1.27; price just above it. 30-day range $1.18–$2.14; price near bottom.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (delta 40-60 only):

Call Volume: $1,610 (100.00%) Put Volume: $0 (0.00%) Total: $1,610

Sentiment: Bullish. 1 call trade, 23 call contracts, 0 puts. Pure directional conviction is call-heavy but sample is tiny (1 trade). Divergence: technicals bearish, options sentiment bullish — confirmed by spread recommendation "Wait for alignment."

Key Price Levels (observational only)

Support (BB Lower)
$1.27
Support (30d Low)
$1.18
Resistance (SMA 5)
$1.41
Resistance (SMA 20/BB Mid)
$1.45
Resistance (BB Upper)
$1.63

Interactive charts load with JavaScript. This text is the crawlable summary.